About the Journal

The International Journal of Pharmacy with Medical Sciences (IJPAMS) is a peer-reviewed, open-access international journal dedicated to advancing research and innovation in the fields of pharmaceutical sciences, medical sciences, and healthcare technologies, with a special emphasis on Artificial Intelligence (AI) applications. The journal serves as a global platform for academicians, researchers, practitioners, and industry professionals to share cutting-edge research, innovative methodologies, and AI-driven approaches that enhance healthcare outcomes.

IJPAMS publishes original research articles, review papers, case studies, short communications, and editorials covering traditional pharmacy and medical domains, as well as emerging areas such as AI, machine learning, data science, and digital health. The journal emphasizes interdisciplinary collaboration between pharmacy, medicine, and computational sciences, aiming to bridge the gap between drug development, AI-assisted diagnostics, clinical applications, and patient care.

Scope of the Journal

The scope of IJPAMS includes, but is not limited to:

Pharmaceutical Sciences: Pharmaceutics, Pharmacology, Pharmacognosy, Pharmaceutical Chemistry, Drug Delivery Systems, Pharmaceutical Biotechnology.
Medical Sciences: Clinical Medicine, Pathology, Microbiology, Biochemistry, Surgery, Public Health, Preventive Medicine.
AI in Pharmacy & Medicine: AI-assisted drug discovery, predictive modeling, diagnostic imaging, personalized medicine, big data analytics in healthcare, pharmacovigilance using AI.
Pharmacy Practice & Clinical Pharmacy: Rational drug use, Pharmacovigilance, Community and Hospital Pharmacy, Clinical Trials with AI-based monitoring.
Interdisciplinary Areas: Nanomedicine, Biotechnology, Biomedical Sciences, Health Informatics, Telemedicine, Regulatory Affairs, and AI-driven healthcare technologies.

Key Features

International Peer-Reviewed Journal ensuring high academic and ethical standards.
Special Focus on AI and Digital Health to drive innovation in pharmacy and medicine.
Open Access to promote visibility and global knowledge sharing.
Rapid Publication Process with a rigorous double-blind review system.
Encourages AI-powered interdisciplinary and translational research connecting pharmaceutical innovations with medical practice.